Exited position

Renaissance Technologies LLC’s Resmed Inc (RMD) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Renaissance Technologies LLCVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ3 2013Earliest verified positive filing snapshot
Latest statusExited positionBased on the latest supported relationship state
Peak shares1.42MHighest verified quarter-end share count
Quarters reported23Verified quarters with shares above zero
What happened?

Renaissance Technologies LLC first reported Resmed Inc in Q3 2013. The reported position was increased and reduced across later filings. The latest verified relationship event shows that Renaissance Technologies LLC sold the entire position in Q1 2026, and the stock is no longer reported in the latest verified portfolio.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q1 2026
Sold the entire position−304.48K shares · No shares reported at quarter-end
Q4 2025
Bought 425.0% more+246.48K shares · 304.48K shares reported after the change
Filing context

Quarter-end price $240.87

Q1 2025
Sold 78.2% of the position−193.70K shares · 54.00K shares remained
Filing context

Quarter-end price $223.85

Q4 2024
Bought 194.9% more+163.70K shares · 247.70K shares reported after the change
Filing context

Quarter-end price $228.69

Q3 2024
Sold 61.7% of the position−135.60K shares · 84.00K shares remained
Filing context

Quarter-end price $244.12

Q2 2024
New position+219.60K shares · 219.60K shares reported
Filing context

Quarter-end price $191.42

Portfolio importance

How important was Resmed Inc in Renaissance Technologies LLC’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Last reported portfolio weight0.1%Q4 2025
Last reported rank#206Rank unavailable
Peak portfolio weight0.2%Q3 2015
Best historical rank#106Q3 2015
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$222.302026-09-23

Market context only; not an investor transaction price.

Latest verified investor filingQ2 2026 · filed 2026-08-13
Open SEC filing ↗

Coverage is bounded to the institution’s top reported positions and material events rather than every security in each Form 13F. The filing reflects reportable U.S.-listed holdings, not Renaissance’s secret models, complete trading book, exact trade dates or execution prices.